Matches in SemOpenAlex for { <https://semopenalex.org/work/W2553963961> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2553963961 abstract "Abstract Abstract 1734 Poster Board I-760 The bone marrow microenvironment can protect leukemic cells from cytotoxic agents, an effect that has been attributed to both soluble- and contact-mediated factors. Recently, we showed that 3 AML cell lines (MV4-11, THP1 and U937) became resistant to 3 promising TKIs (sorafenib, sunitinib and midostaurin) in a coculture model with mesenchymal cells (MSCs) (Shimada A. et al. Proceedings ASH 2008). In the current investigation, we show that 9 primary AML blast samples (including 7 with wild-type FLT3 and 2 with FLT3-interal tandem duplications) were less sensitive to 10 μM sorafenib in coculture with MSCs vs. suspension culture [mean percentage of total annexin V positive cells, 25% (range, 17-32%) vs. 36% (range, 31-47%)]. We explored potential mechanisms of resistance in AML cell lines. No alterations in drug intracellular accumulation, FLT3 receptor expression/phosphorylation, or acquired mutations in the FLT3, NRAS or KRAS genes were observed in AML cells in coculture with MSCs. However, we found that contact with AML cells enhanced the secretion of IL-6, IL-8, and VCAM-1 by MSCs. In parallel, multiple signaling pathways were activated in AML cells by MSCs including PI3K/AKT, STAT, ERK, and NFKB. Sorafenib-induced inhibition of phosphoproteins in the PI3K/AKT and ERK pathways was decreased in coculture vs. suspension culture. We evaluated PI103, a selective and potent inhibitor of class I PI3K isoforms, as a potential strategy to overcome TKI resistance in the microenvironment. In 3 AML cell lines, the antileukemic activity of PI103 in combination with each of the 3 TKIs was enhanced to a greater extent in coculture than in suspension culture, which was associated with more effective inhibition of both phospho-AKT and phospho-p70 S6 kinase. In primary AML blast samples, the combination of 1.0 μM PI103 + 10.0 μM sorafenib induced more apoptosis [mean percentage of total annexin V positive cells, 38% (range, 32-47%)] than either agent alone [sorafenib, 25% (16-32%); PI103, 24% (20-36%)]. In conclusion, inhibition of PI3K/AKT signaling represents a potential treatment strategy to restore TKI sensitivity in the microenvironment. Disclosures No relevant conflicts of interest to declare." @default.
- W2553963961 created "2016-11-30" @default.
- W2553963961 creator A5010068577 @default.
- W2553963961 creator A5034265050 @default.
- W2553963961 creator A5036019071 @default.
- W2553963961 creator A5065331155 @default.
- W2553963961 creator A5066681200 @default.
- W2553963961 creator A5075936752 @default.
- W2553963961 creator A5077260725 @default.
- W2553963961 date "2009-11-20" @default.
- W2553963961 modified "2023-10-07" @default.
- W2553963961 title "Inhibition of Class I PI3K Isoforms Restores the Sensitivity of Acute Myelogenous Leukemia Cells to Multi-Tyrosine Kinase Inhibitors in the Bone Marrow Microenvironment." @default.
- W2553963961 doi "https://doi.org/10.1182/blood.v114.22.1734.1734" @default.
- W2553963961 hasPublicationYear "2009" @default.
- W2553963961 type Work @default.
- W2553963961 sameAs 2553963961 @default.
- W2553963961 citedByCount "0" @default.
- W2553963961 crossrefType "journal-article" @default.
- W2553963961 hasAuthorship W2553963961A5010068577 @default.
- W2553963961 hasAuthorship W2553963961A5034265050 @default.
- W2553963961 hasAuthorship W2553963961A5036019071 @default.
- W2553963961 hasAuthorship W2553963961A5065331155 @default.
- W2553963961 hasAuthorship W2553963961A5066681200 @default.
- W2553963961 hasAuthorship W2553963961A5075936752 @default.
- W2553963961 hasAuthorship W2553963961A5077260725 @default.
- W2553963961 hasConcept C185592680 @default.
- W2553963961 hasConcept C198826908 @default.
- W2553963961 hasConcept C203014093 @default.
- W2553963961 hasConcept C2778019345 @default.
- W2553963961 hasConcept C2778461978 @default.
- W2553963961 hasConcept C2778695046 @default.
- W2553963961 hasConcept C2780007613 @default.
- W2553963961 hasConcept C502942594 @default.
- W2553963961 hasConcept C54355233 @default.
- W2553963961 hasConcept C57074206 @default.
- W2553963961 hasConcept C62478195 @default.
- W2553963961 hasConcept C81885089 @default.
- W2553963961 hasConcept C86554907 @default.
- W2553963961 hasConcept C86803240 @default.
- W2553963961 hasConcept C95444343 @default.
- W2553963961 hasConceptScore W2553963961C185592680 @default.
- W2553963961 hasConceptScore W2553963961C198826908 @default.
- W2553963961 hasConceptScore W2553963961C203014093 @default.
- W2553963961 hasConceptScore W2553963961C2778019345 @default.
- W2553963961 hasConceptScore W2553963961C2778461978 @default.
- W2553963961 hasConceptScore W2553963961C2778695046 @default.
- W2553963961 hasConceptScore W2553963961C2780007613 @default.
- W2553963961 hasConceptScore W2553963961C502942594 @default.
- W2553963961 hasConceptScore W2553963961C54355233 @default.
- W2553963961 hasConceptScore W2553963961C57074206 @default.
- W2553963961 hasConceptScore W2553963961C62478195 @default.
- W2553963961 hasConceptScore W2553963961C81885089 @default.
- W2553963961 hasConceptScore W2553963961C86554907 @default.
- W2553963961 hasConceptScore W2553963961C86803240 @default.
- W2553963961 hasConceptScore W2553963961C95444343 @default.
- W2553963961 hasLocation W25539639611 @default.
- W2553963961 hasOpenAccess W2553963961 @default.
- W2553963961 hasPrimaryLocation W25539639611 @default.
- W2553963961 hasRelatedWork W2010898909 @default.
- W2553963961 hasRelatedWork W2032403766 @default.
- W2553963961 hasRelatedWork W2047679485 @default.
- W2553963961 hasRelatedWork W2066680949 @default.
- W2553963961 hasRelatedWork W2117303613 @default.
- W2553963961 hasRelatedWork W2129573915 @default.
- W2553963961 hasRelatedWork W2517481179 @default.
- W2553963961 hasRelatedWork W2530792765 @default.
- W2553963961 hasRelatedWork W2531031953 @default.
- W2553963961 hasRelatedWork W2552271317 @default.
- W2553963961 hasRelatedWork W2557455612 @default.
- W2553963961 hasRelatedWork W2559646886 @default.
- W2553963961 hasRelatedWork W2589097797 @default.
- W2553963961 hasRelatedWork W2626761184 @default.
- W2553963961 hasRelatedWork W2771443296 @default.
- W2553963961 hasRelatedWork W2807521243 @default.
- W2553963961 hasRelatedWork W2914799005 @default.
- W2553963961 hasRelatedWork W2954016812 @default.
- W2553963961 hasRelatedWork W2979818067 @default.
- W2553963961 hasRelatedWork W3106716740 @default.
- W2553963961 isParatext "false" @default.
- W2553963961 isRetracted "false" @default.
- W2553963961 magId "2553963961" @default.
- W2553963961 workType "article" @default.